Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Oncology
Partner With Us
Advertisement

Jennifer Brown, MD, PhD reviews Phase 2 Amplify trial

Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.

Dana-Farber

Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.